The stark inequity in safe, affordable housing due to unfair policies and practices (e.g., redlining) underpins inequities across multiple social determinants of health (SDOH) and health outcomes.

A four-tier model offers a pragmatic framework for establishing meaningful measurements that will advance equity for patients and for the staff of the organization.

Health care leaders are often surprised to learn that their operations contribute significantly to a warming climate. In addition to their roles as responders to and victims of extreme weather events, ...

Rising-risk patients receiving Medicaid experience worsening medical and behavioral health conditions and increased acute care (ED and hospital) utilization, while typically being disconnected from ...

A large academic medical center found substantial opportunities for cost savings at three non–emergency department sites relative to the ED, especially telehealth.

A dedicated multidisciplinary post-ICU recovery unit for Covid-19 patients addresses their unique complexities and lets them begin rehabilitation earlier than they would with a normal progression from ...

Especially important during a pandemic, health care’s common challenge is making sure how we deliver care and change the structures of society actually contributes to the health of the people we ...

How Cleveland Clinic initiated a multidisciplinary program to reduce time-to-treatment and accomplish a 33% reduction.

The burden of clinical documentation has become an enormous challenge for health care systems, contributing to clinician burnout, job dissatisfaction, and impaired physician–patient interactions that ...

The very nature of this global public health crisis presents not just clinical challenges, but organizational and managerial ones as well. Together, health care staff — from the front lines to the ...

Integrated pain management programs are key to fighting opioid abuse, but they face significant challenges in financing, access, and public understanding.

Are we paying too much for new drugs before we know how well they work? This innovative pricing model proposes postponing major rewards until efficacy is established — which could help both patients ...